119 related articles for article (PubMed ID: 34393059)
1. Knowledge-based dose prediction models to inform gynecologic brachytherapy needle supplementation for locally advanced cervical cancer.
Kallis K; Mayadev J; Kisling K; Brown D; Scanderbeg D; Ray X; Cortes K; Simon A; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
Brachytherapy; 2021; 20(6):1187-1199. PubMed ID: 34393059
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of dose differences between intracavitary applicators for cervical brachytherapy using knowledge-based models.
Kallis K; Mayadev J; Covele B; Brown D; Scanderbeg D; Simon A; Frisbie-Firsching H; Yashar CM; Einck JP; Mell LK; Moore KL; Meyers SM
Brachytherapy; 2021; 20(6):1323-1333. PubMed ID: 34607771
[TBL] [Abstract][Full Text] [Related]
3. Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy.
Stenhouse K; Roumeliotis M; Ciunkiewicz P; Martell K; Quirk S; Banerjee R; Doll C; Phan T; Yanushkevich S; McGeachy P
Brachytherapy; 2024; 23(3):368-376. PubMed ID: 38538415
[TBL] [Abstract][Full Text] [Related]
4. A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer.
Ladbury C; Harkenrider M; Taunk N; Fisher C; Mayadev J; Venkat P; Yashar C; Gaffney D; Beriwal S; Glaser S
Brachytherapy; 2023; 22(5):640-648. PubMed ID: 37481370
[TBL] [Abstract][Full Text] [Related]
5. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
[TBL] [Abstract][Full Text] [Related]
6. Predicting which patients may benefit from the hybrid intracavitary+interstitial needle (IC/IS) applicator for advanced cervical cancer: A dosimetric comparison and toxicity benefit analysis.
Gonzalez Y; Giap F; Klages P; Owrangi A; Jia X; Albuquerque K
Brachytherapy; 2021; 20(1):136-145. PubMed ID: 33132073
[TBL] [Abstract][Full Text] [Related]
7. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
Takagawa Y; Izumi S; Takahashi E; Kita M
BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783
[TBL] [Abstract][Full Text] [Related]
8. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
9. The addition of interstitial needles to intracavitary applicators in the treatment of locally advanced cervical cancer: Why is this important and how to implement in low- and middle-income countries?
Lombe D; Crook J; Bachand F; Moore J; Hamm J; Rose T; Anderson D; Batchelar D
Brachytherapy; 2020; 19(3):316-322. PubMed ID: 32229073
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
[TBL] [Abstract][Full Text] [Related]
11. Design approach and benefits of the 3D-printed vaginal individualized applicator (VIA).
Ewongwo A; Niedermayr T; Kidd EA
Brachytherapy; 2024; 23(3):282-289. PubMed ID: 38402047
[TBL] [Abstract][Full Text] [Related]
12. Direction Modulated Brachytherapy for Treatment of Cervical Cancer. II: Comparative Planning Study With Intracavitary and Intracavitary-Interstitial Techniques.
Han DY; Safigholi H; Soliman A; Ravi A; Leung E; Scanderbeg DJ; Liu Z; Owrangi A; Song WY
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):440-448. PubMed ID: 27598809
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric evaluation of the feasibility of utilizing a reduced number of interstitial needles in combined intracavitary and interstitial brachytherapy for cervical cancer.
Jahan D; Ahmad S; Thompson S; Schnell E
J Appl Clin Med Phys; 2023 Feb; 24(2):e13833. PubMed ID: 36355039
[TBL] [Abstract][Full Text] [Related]
14. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame.
Trnková P; Pötter R; Baltas D; Karabis A; Fidarova E; Dimopoulos J; Georg D; Kirisits C
Radiother Oncol; 2009 Nov; 93(2):331-40. PubMed ID: 19846230
[TBL] [Abstract][Full Text] [Related]
15. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K
Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344
[TBL] [Abstract][Full Text] [Related]
16. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
[TBL] [Abstract][Full Text] [Related]
17. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
[TBL] [Abstract][Full Text] [Related]
18. Individualized and inverse optimized needle configuration for combined intracavitary-interstitial brachytherapy in locally advanced cervical cancer.
Zhang D; Yang Z; Jiang S; Zhou L; Zhou Z; Wang W
J Cancer Res Ther; 2019; 15(7):1589-1596. PubMed ID: 31939442
[TBL] [Abstract][Full Text] [Related]
19. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
[TBL] [Abstract][Full Text] [Related]
20. Intracavitary combined with CT-guided interstitial brachytherapy for locally advanced uterine cervical cancer: introduction of the technique and a case presentation.
Wakatsuki M; Ohno T; Yoshida D; Noda SE; Saitoh J; Shibuya K; Katoh H; Suzuki Y; Takahashi T; Nakano T
J Radiat Res; 2011; 52(1):54-8. PubMed ID: 21293072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
